Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Novo Nordisk recently published favorable results from the FLOW renal outcomes trial, which found that Ozempic (semaglutide) 1.0 mg lowered the risk of kidney disease progression and kidney and ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

THEY'RE ADVERTISED AS OZEMPIC OR WEGOVY. 12;40;15;00 THE GENERIC NAME IS SEMAGLUTIDE, THESE ARE IN A CLASS OF MEDICATIONS CALLED GLP1. DR. COHEN SAYS THIS IS A NATURALLY OCCURING HORMONE THAT CUES ...

The FDA approves Ozempic for the treatment of chronic kidney disease in patients who also have type 2 diabetes. Ozempic and other diabetes drugs known as GLP-1s have become popular and also well ...

Ozempic reduces snack sales by 6%-9%, reshaping the food industry. Cannabis legalization boosts junk food purchases by 9%, fueling munchies. Industries adapt with new ...